Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial. (Q51001453)
Jump to navigation
Jump to search
scientific article published on 10 May 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial. |
scientific article published on 10 May 2013 |
Statements
Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial (English)
Sandor Fritsch
Hartmut J Ehrlich
P Noel Barrett
Peter G Kremsner
Nina Wressnigg
Eva-Maria Pöllabauer
Gerald Aichinger
Daniel Portsmouth
Alexandra Löw-Baselli
Ian Livey
Brian A Crowe
Michael Schwendinger
Peter Brühl
Andreas Pilz
Thomas Dvorak
Julia Singer
Bernhard Schmitt
Markus Müller
Maria Paulke-Korinek